Abelacimab Active Not Recruiting Phase 2 Trials for Atrial Fibrillation / Stroke Supportive Care

Indications	Status	Purpose	Phase
DBCOND0000503 (Atrial Fibrillation) DBCOND0020609 (Stroke)	Active Not Recruiting	Supportive Care	2

clinicaltrials.gov Identifier	Title	Drugs
NCT04755283	Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation	Abelacimab (DB16682) Rivaroxaban (DB06228)